Lactobacillus Crispatus en el tratamiento de virus de papiloma humano en mujeres

Abstract

Lactobacillus crispatus is vital for the homeostasis of the cervicovaginal microbiota. Its usefulness provides new approaches to treating Human Papillomavirus (HPV) in women. Several studies support the efficacy of this prebiotic as a preventive method against HPV. The authors emphasize that although there is no evidence that Lactobacillus crispatus eradicates high-risk HPV, there is a significant improvement in the presentation of symptoms. For this reason, this literature review focuses on providing updated information that may be useful to prevent women from continuing to lose their lives to this pathology. All authors in this review agree that the number of L. crispatus present in the vaginal microbiome is directly related to the severity of high-risk HPV presentation. Although healthy and HPV-infected women have similar microbiota, the number of healthy microorganisms makes the difference. This is why HPV directly influences the presentation of vaginal pathogenic bacteria.